A coalition of prominent scientists and academic researchers has filed a high-stakes class-action lawsuit against the National Institutes of Health (NIH), alleging that the federal agency has implemented a systematic, viewpoint-based censorship regime by screening grant applications for "disfavored" words and phrases. The lawsuit, filed in federal court by 13 named plaintiffs and four anonymous researchers, marks a significant escalation in the ongoing conflict between the scientific community and the current administration’s efforts to reshape the priorities of the nation’s premier biomedical research institution. The plaintiffs argue that the NIH’s use of computational tools to identify and purge research related to climate change, diversity, equity, and public health disparities constitutes a direct violation of the First Amendment’s protection of free speech and academic inquiry.
The legal challenge seeks to immediately halt the practice of "keyword scrubbing," a process where NIH officials allegedly scan both new applications and existing grants for specific terms to determine whether they should be rejected, defunded, or "renegotiated." According to the complaint, the screening process has targeted a wide array of topics that the Trump administration has signaled as politically unfavorable. These include efforts to diversify the scientific workforce, studies on the social determinants of health, investigations into the health impacts of climate change, and research regarding vaccine efficacy and distribution. Because the case has been filed as a class action, a favorable ruling for the plaintiffs would have sweeping implications, potentially protecting thousands of researchers across the United States whose work has been flagged or suppressed by these linguistic filters.
This legal battle is the latest chapter in a broader ideological struggle that began when President Trump returned to office in 2025. Upon his inauguration, the administration moved swiftly to align the multi-billion-dollar federal research portfolio with its specific policy goals. Early efforts focused on the mass termination of existing grants, particularly those involving environmental health and racial disparities. However, these initial "slap-dash" terminations hit a major legal roadblock in June 2025, when a federal judge ruled that the abrupt cancellations violated the Administrative Procedures Act (APA). The court found that the agency had failed to provide a reasoned explanation for the policy shifts, rendering the cuts illegal. While hundreds of grants were subsequently reinstated, the administration reportedly pivoted to a more subtle, yet equally pervasive, method of control: linguistic oversight.
Following the 2025 court ruling, the NIH allegedly shifted its strategy from wholesale cancellations to a process of "renegotiation." Internal documents and testimonies from NIH employees suggest that grantees were increasingly pressured to "tweak" the language of their projects to remain eligible for funding. Data analysis from late 2025 revealed that over 700 researchers were forced to change the titles of their studies to remove words like "equity," "disparity," "racism," and "gender identity." This process was not merely manual; the lawsuit alleges the NIH deployed a sophisticated "computational text analysis" tool designed to flag "problematic" terminology across the agency’s entire portfolio of tens of thousands of active grants.
Olga Akselrod, a senior counsel at the American Civil Liberties Union (ACLU) representing the researchers, described the agency’s actions as a "viewpoint-based purge." Akselrod noted that while the previous court victory in the APA case provided temporary relief, the NIH simply adapted its tactics to achieve the same result. "NIH supplemented the directives at issue in previous litigation with a series of additional guidance and policies that purported to replace the vacated directives, but in fact just continued the purge," Akselrod stated. "It is a deliberate attempt to use the power of the federal purse to silence scientific inquiry that doesn’t fit a specific political narrative."
The human and scientific cost of this policy is reflected in the testimony of the plaintiffs. Arghavan Salles, a prominent researcher and one of the named plaintiffs, had her R01 grant—a prestigious and highly competitive NIH funding vehicle—terminated. Her research focused on the prevalence and impact of sexual harassment experienced by scientists during their professional training. Despite the critical nature of her work in improving the safety and productivity of the research workforce, her funding was not reinstated after the 2025 ruling. Salles reports that she has since struggled to secure new funding because she is effectively barred from using the technical vocabulary of her field.

"I couldn’t talk about my research on implicit bias, microaggressions, sexual harassment, or belonging," Salles said in a recent interview. "I couldn’t use any of those words. It is fundamentally impossible to demonstrate expertise or leadership in a specialized field when the government forbids you from using the very terms that define that field. It’s like asking a cardiologist to describe heart disease without using the word ‘artery.’"
The lawsuit highlights a growing disconnect between the public statements of NIH leadership and the internal operations of the agency. NIH Director Jay Bhattacharya has repeatedly and publicly denied the existence of any "banned word" lists. In a July 2026 interview with the conservative advocacy group PragerU, Bhattacharya insisted, "I am deeply against banned word lists. I don’t believe in them. I will not have my institution embrace them." However, this stance appears to be contradicted by legal stipulations filed by other NIH officials. In a separate court case involving University of California researchers, the NIH’s own head of extramural research admitted in writing that the agency "used search terms, keywords, or phrases to identify and terminate grants presumed to express viewpoints—such as subjects and/or topics of the grant—that HHS-NIH no longer wished to subsidize."
This internal contradiction is a central pillar of the plaintiffs’ argument. They contend that the NIH is operating a "shadow policy" that bypasses traditional peer-review processes in favor of ideological screening. For decades, the NIH grant process has been considered the gold standard of scientific meritocracy, relying on panels of independent experts to evaluate the scientific rigor and potential impact of proposed research. The introduction of political keyword filters, the plaintiffs argue, subverts this process and replaces scientific excellence with political loyalty.
The impact of these policies extends beyond the immediate loss of funding; it is creating a profound "chilling effect" across the American academic landscape. Michael Green, a social epidemiologist at Johns Hopkins University and a plaintiff in the suit, has experienced this firsthand. Green’s research focuses on the long-term health effects of discrimination in medical settings, specifically how these experiences contribute to cardiovascular and cognitive decline in aging Black adults. When Green first applied for his grant in 2023, his work was highly praised for its potential to address significant public health gaps. However, by 2025, during the transition phase of his grant, he was told he must "sanitize" his project description.
The original title of his project, "Assessing the Impact of Discrimination in Healthcare on the Cardiovascular and Cognitive Health of Aging Black Adults," was forcibly changed. To maintain his funding, Green was required to remove the words "discrimination" and "Black." For Green, the lack of transparency is as damaging as the censorship itself. "To this day, I didn’t get clarity on why my work was targeted," he said. "The opacity has made it impossible to trust the agency. The main draw of academia—the ability to ask difficult questions to better understand the world—now feels incredibly tenuous. I’ve stopped applying for NIH grants altogether because I don’t want to participate in a system where my vocabulary is policed by political appointees."
Legal experts suggest the case could reach the Supreme Court, as it touches on the "unconstitutional conditions" doctrine—the principle that the government cannot condition a benefit, such as a research grant, on the recipient surrendering their First Amendment rights. While the government has broad latitude to decide what it wants to fund, it is generally prohibited from discriminating based on the specific viewpoint expressed by the speaker. By targeting words like "racism" or "climate change," the plaintiffs argue the NIH is not merely choosing different research topics, but is actively suppressing specific scientific perspectives.
The broader scientific community warns that if the NIH continues down this path, the United States risks a "brain drain" of its top talent to other countries or the private sector. Furthermore, the loss of data on health disparities and environmental impacts could have long-term consequences for national health policy, leaving the government ill-equipped to handle future pandemics or the health effects of a changing climate. As the lawsuit moves forward, the scientific world remains on edge, waiting to see if the judiciary will restore the traditional boundaries between federal funding and academic freedom. For now, the NIH has declined to comment on the pending litigation, leaving the future of American biomedical research in a state of profound uncertainty.

